These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 8769749)

  • 1. Comparative cardioprotective effects of cromakalim and diltiazem in ischemic hypertrophied rat hearts.
    Grover GJ; Dzwonczyk S; Monticello TM
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H174-82. PubMed ID: 8769749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.
    Grover GJ; Sleph PG; Dzwonczyk S; Malone HJ; Behling RW
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):28-38. PubMed ID: 9007667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs.
    Grover GJ; Sleph PG; Dzwonczyk S
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):853-64. PubMed ID: 1704976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac mechanical dysfunction induced by ischemia-reperfusion in perfused heart isolated from stroke-prone spontaneously hypertensive rats.
    Itoh T; Abe K; Tokumura M; Hirono S; Haruna M; Ibii N
    Clin Exp Hypertens; 2004 Aug; 26(6):485-98. PubMed ID: 15554452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial function in normal and spontaneously hypertensive rats during reperfusion after a period of global ischaemia.
    Snoeckx LH; van der Vusse GJ; Coumans WA; Willemsen PH; van der Nagel T; Reneman RS
    Cardiovasc Res; 1986 Jan; 20(1):67-75. PubMed ID: 2939955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicorandil improves postischemic contractile function independently of direct myocardial effects.
    Grover GJ; Sleph PG; Parham CS
    J Cardiovasc Pharmacol; 1990 May; 15(5):698-705. PubMed ID: 1692928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
    J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
    Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
    Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of a pharmacologic interaction between ATP-sensitive potassium channels and adenosine A1 receptors in ischemic rat hearts.
    Grover GJ; Baird AJ; Sleph PG
    Cardiovasc Res; 1996 Apr; 31(4):511-7. PubMed ID: 8689642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilating actions of cromakalim in resting and contracting states of carotid arteries from spontaneously hypertensive rats.
    Asano M; Masuzawa-Ito K; Matsuda T
    Eur J Pharmacol; 1994 Sep; 263(1-2):121-31. PubMed ID: 7529710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog.
    D'Alonzo AJ; Darbenzio RB; Sewter JC; Hess TA; Grover GJ; Sleph PG; Normandin DE; Lodge NJ
    Eur J Pharmacol; 1995 Dec; 294(1):271-80. PubMed ID: 8788441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solution.
    Grover GJ; Sleph PG
    J Cardiovasc Pharmacol; 1995 Nov; 26(5):698-706. PubMed ID: 8637183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardioprotective effect of cromakalim, a K+ channel opener, on isolated globally ischemic and reperfused rat hearts].
    Taki H; Masuda Y; Yoshizumi M; Kitagawa T; Katoh I
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):438-44. PubMed ID: 8478573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
    Grover GJ; D'Alonzo AJ; Sleph PG; Dzwonczyk S; Hess TA; Darbenzio RB
    J Pharmacol Exp Ther; 1994 May; 269(2):536-40. PubMed ID: 8182522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
    Venkatesh N; Stuart JS; Lamp ST; Alexander LD; Weiss JN
    Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.
    Grover GJ; Newburger J; Sleph PG; Dzwonczyk S; Taylor SC; Ahmed SZ; Atwal KS
    J Pharmacol Exp Ther; 1991 Apr; 257(1):156-62. PubMed ID: 2019983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia.
    D'Alonzo AJ; Darbenzio RB; Hess TA; Sewter JC; Sleph PG; Grover GJ
    Cardiovasc Res; 1994 Jun; 28(6):881-7. PubMed ID: 7923295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The KATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat hearts.
    Grover GJ; Murray HN; Baird AJ; Dzwonczyk S
    Eur J Pharmacol; 1995 Apr; 277(2-3):271-4. PubMed ID: 7493619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.